Most older Americans are troubled by low-level depression or sleep disturbances, which are often intimately intertwined. In the first 5 years of AG12364, they have been examining the etiologies of depression and insomnia in aging volunteers. Their findings suggest an appalling degree of circadian malsynchronization among aging Americans, which possibly explains part of their insomnia and low mood. Further, their volunteers displayed surprisingly weak circadian and clinical responses to 4 days of bright light treatment, indicating possible light resistance. In this renewal, they will test more extended 4-week bright light treatments in the home, to determine if light resistance in volunteers ages 60-79 years can be overcome with a longer duration of treatment. One hundred fifty volunteers with significant depressive complaints will be recruited for a trial consisting of one-week placebo baseline terminating in a half-night sleep deprivation, followed by 4 weeks randomized assignment to 10,000 lux white light or 10 lux red light placebo. Phase-typing during baseline will determine before randomization whether treatment should best be given in the morning, mid-day, or evening. Fractional urine samples for 6-sulphatoxymelatonin will be collected for 48 hours at the end of baseline and for 48 hours at the end of the randomized treatment, to determine if 10,000 lux treatments successfully normalize malsynchronized circadian phase adjustments. The success of the treatment in lowering the GDS depression score and in reducing sleep complaints will be examined.
Grandner, Michael A; Kripke, Daniel F; Naidoo, Nirinjini et al. (2010) Relationships among dietary nutrients and subjective sleep, objective sleep, and napping in women. Sleep Med 11:180-4 |
Niko Verdecias, R; Jean-Louis, Girardin; Zizi, Ferdinand et al. (2009) Attachment styles and sleep measures in a community-based sample of older adults. Sleep Med 10:664-7 |
Park, Doo Heum; Kripke, Daniel F; Louis, Girardin Jean et al. (2007) Self-reported sleep latency in postmenopausal women. J Korean Med Sci 22:1007-14 |
Jean-Louis, Girardin; Zizi, Ferdinand; Dweck, Monica et al. (2007) Ophthalmic dysfunction in a community-based sample: influence of race/ethnicity. J Natl Med Assoc 99:141-4, 147-8 |
Nievergelt, Caroline M; Kripke, Daniel F; Barrett, Thomas B et al. (2006) Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 141B:234-41 |
Loving, Richard T; Kripke, Daniel F; Knickerbocker, Nancy C et al. (2005) Bright green light treatment of depression for older adults [ISRCTN69400161]. BMC Psychiatry 5:42 |
Jean-Louis, G; Kripke, D; Cohen, C et al. (2005) Associations of ambient illumination with mood: contribution of ophthalmic dysfunctions. Physiol Behav 84:479-87 |
Jean-Louis, G; Zizi, F; Casimir, G et al. (2005) Sleep-disordered breathing and hypertension among African Americans. J Hum Hypertens 19:485-90 |
Kripke, D F; Youngstedt, S D; Elliott, J A et al. (2005) Circadian phase in adults of contrasting ages. Chronobiol Int 22:695-709 |
Nievergelt, Caroline M; Kripke, Daniel F; Remick, Ronald A et al. (2005) Examination of the clock gene Cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association. Psychiatr Genet 15:45-52 |
Showing the most recent 10 out of 42 publications